Could Merck Become Pharma's Yield King? Analyst expects the company will boost dividend after its merger with Schering-Plough. Matthew Herper, 05.29.09, Originally published in Forbes.com Merck could increase the size of the dividend payment it makes to shareholders every … [Read more...] about Merck Merger Mints Money
Schering-Plough
Merck Puts Some of Their Gardasil Cash To Work
Merck to buy Schering-Plough in $41 billion deal Reported by David Jolly Publ With the purchase, Merck is expanding its franchise in cardiovascular, respiratory and oncology drugs and shoring up its research pipeline, in particular with a Schering-Plough product called TRA, a … [Read more...] about Merck Puts Some of Their Gardasil Cash To Work